Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.1 USD | -2.58% |
|
-2.44% | -33.18% |
06-26 | Deutsche Bank Upgrades Repligen to Buy From Hold, Cuts Price Target to $155 From $180 | MT |
06-24 | RBC Cuts Price Target on Repligen to $190 From $221, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.18% | 6.71B | |
-6.24% | 180B | |
-6.08% | 99.21B | |
-5.98% | 66.25B | |
-9.35% | 44.74B | |
+8.34% | 43.82B | |
+10.35% | 41.96B | |
+11.88% | 28.98B | |
-8.38% | 23.5B | |
+16.18% | 24.07B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Transcript : Repligen Corporation Presents at 35th Annual JP Morgan Healthcare Conference, Jan-12-2017 11